Clinical trial
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
NCT02304432 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
- Lead sponsor
- Mclean Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 27, 2015
- Completion date
- July 31, 2017
- Enrollment
- 2 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.